MSeqDR Mitochondrial Disease Portal


 
*:HP: HPO terms, ND: NAMDC terms.
  Most Studied  CPEO, Complex I Deficiency, COXPD1, Leigh, LHON, MELAS, MERRF, NARP, SANDO
Could not execute query 3
SELECT t5.Variation_Name, t5.GeneID, t5.GeneSymbol, t5.ClinicalSignificance, t5.dbSNP, t5.RCVaccession, t5.TestedInGTR, t5.PhenotypeIDs, t5.Chromosome, t5.Start, t5.Stop, t5.HGVS_c, t5.HGVS_p, t5.HGVS_g, t5.OtherIDs, t5.Diseases as Disease_ClinVar FROM gb_exome.clinvar_variation_v2_latest as t5 WHERE Assembly ='GRCh37' AND (t5.PhenotypeIDs like '%:616540%' OR t5.otherIDs like '%OMIM Allelic Variant:616540%' ) ORDER by GeneSymbol, t5.ClinicalSignificance LIKE 'Patho%' DESC, t5.ClinicalSignificance LIKE '%likely pathog%' DESC, start <1,start;
Term ID:14685
Name:progressive myoclonic epilepsy type 9
Definition:Any progressive myoclonic epilepsy in which the cause of the disease is a mutation in the LMNB2 gene.
Alternative IDs:616540
ParentIDs:
TreeNumbers:
Synonyms:epilepsy, progressive myoclonic, 9; epilepsy, progressive myoclonic, 9; EPM9; epilepsy, progressive myoclonic, type 9; EPM9; LMNB2 progressive myoclonic epilepsy; PME type 9; progressive myoclonic epilepsy caused by mutation in LMNB2; progressive myoclonic epilepsy due to LMNB2 deficiency; progressi
Slim Mappings:
Reference: MedGen:
MeSH:
OMIM: 616540;
MSeqDR LSDB:  
Genes: